thyroid-associated ophthalmopathy extraocular muscular atrophy
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: patients: (a) People twenty years old and over at the time of the consent. (b) patients with thyroid-associated ophthalmopathy of extraorbiral muscular atrophy. (c) people who don't have other orbital abnormality. (d) People who can consent to this study in writing. control: (a) People twenty years old and over at the time of the consent. (b) people who don't have any orbital abnormality. (c) People who can consent to this study in writing.
Exclusion criteria
Exclusion criteria: (a) Contraindication to MRI(cardiac pacemaker; cochlear implantation device; defibrillator; neurostimulator; bone growth stimulation device; infusion pump; deep brain stimulation; cervical artery crump(Poppen-Blaylock); chip of ferromagnetic substance in eyeball, brain, internal organs, lung, mediastinum; intraaortic filter, intravascular coil or stent within 2 months, claustrophobia, tattoo, pregnancy or likelihood of pregnancy) (b) People who were unsuitable for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| A comparison of maximum cross-section of extraocular muscles and orbital fat volume of patients with thyroid-associated ophthalmopathy at before and after treatment. | — |
Secondary
| Measure | Time frame |
|---|---|
| (a) The association between CAS (clinical activity score) and maximum cross-section of extraocular muscles/ orbital fat volume of patients with thyroid-associated ophthalmopathy. (b) A comparison of maximum cross-section of extraocular muscles between patients with thyroid-associated ophthalmopathy, patients with extraorbital muscular atrophy and controls. (c) A comparison of orbital fat volume between patients with thyroid-associated ophthalmopathy and controls. | — |
Countries
Japan
Contacts
Institute of Biomedical and Health Sciences, Hiroshima University Diagnostic Radiology